BOSTON -- NanoMosaic Inc., the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for proteomics, genomics, and single-run experiment multi-omics applications, has announced its second commercial sale, to Massachusetts General Hospital (MGH) as part of its Early Access Program. NanoMosaic previously announced that it had placed a beta system at MGH for proteomic neurological diagnostic [...]

Genomenon announced Tuesday that it was awarded a $1.7 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health to help it organize and connect patient DNA to global genomic research in the areas of rare genetic diseases and cancer. The grant is the latest in a steady stream of company advances highlighted by the addition [...]

End-to-end solution combines cryogenic and cold chain logistics, serialization compliance and global distribution WALTHAM, Mass. -- Cell and gene therapy innovators can now leverage new integrated commercial packaging and distribution services from Thermo Fisher Scientific, designed to seamlessly transition therapies from clinic to commercial launch for patients across the U.S. and Europe. The Patheon Commercial Packaging Services for [...]

$40 million expansion will support increased production of single-use technology for critical vaccines and biologics WALTHAM, Mass. -- Thermo Fisher Scientific is investing $40 million to expand its single-use technology (SUT) manufacturing facility in Millersburg, Pa. The expansion is part of the company’s $650 million multi-year investment, announced last year, to help ensure flexible, scalable and [...]

Library will enable analytical labs to identify potential E&L compounds in their samples using instruments from Waters and confirm the identity using MilliporeSigma's Supelco® reference materials Collaboration to provide testing labs with unrivalled confidence in their results and enhance consumer safety Burlington, Massachusetts – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, [...]

Facility brings new microscopy and imaging capabilities to Texas A&M researchers WALTHAM, Mass. — Olympus is proud to announce the opening of the Olympus Discovery Center at Texas A&M Health to support research focused on treating, alleviating and preventing human diseases. The new facility provides researchers with hands-on access to Olympus microscopy systems that meet [...]

Microtrac MRB and Colloid Metrix GmbH announce that effective February 15th, 2022 Microtrac MRB has acquired the STABINO™ product line from Colloid Metrix. The STABINO™ has been established as a worldwide standard for the measurement of zeta potential and stability in suspensions and emulsions for many years. “We are excited to continue this great legacy” [...]

AVIPure® affinity resins address the market need for high performance and caustic stability WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of three advanced affinity chromatography resins for use in gene therapy manufacturing workflows. The resins – AVIPure® - AAV9, AVIPure® - AAV8, and AVIPure® - [...]

Founder and Executive Chairman of the Board to Advance Quantum-Si’s Protein Sequencing Technology and Commercialization Strategy GUILFORD, Conn. -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced the appointment of Dr. Jonathan Rothberg, Founder and Executive Chairman of Quantum Si’s Board of Directors, as [...]

HERCULES, Calif. -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of a range of anti-daratumumab antibodies that are specific for daratumumab (Darzalex) and inhibit the binding of the drug to its target, CD38. These highly specific and high-affinity recombinant antibodies [...]